Because some cancer prognostic factors such as VEGF, Bcl-2 and survivin are the downstream genes of STAT3 signaling, the constitutive STAT3 activation may lead to unfavorable outcomes for the large-cell and classic medulloblastomas. This evidence concerns the gene BCL2 and cancer.